CP Stent (Model 425), Covered CP Stent (Model 427), Mounted CP Stent (Model 426), Covered and Mounted CP Stent (Model 42
NuMED, Inc. · Decision date Jul 6, 2026
What did the FDA approve?
FDA records P150028/S007 as a supplement to PMA P150028, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Jul 6, 2026.
FDA approval order statement
approval for a manufacturing site located at Sterigenics U.S., LLC, 84 Park Road, Queensbury, NY 12804 as a contract sterilization facility, and modifications to reduce the ethylene oxide concentration at the existing contract sterilization facility at Cosmed Group (Lynx Medical) at 2205 East 33rd Street, Erie, PA, 16510
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Cardiovascular
- Decision date
- Jul 6, 2026
- FDA change category
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P150028/S007
- Regulatory pathway
- PMA supplement
- Applicant
- NuMED, Inc.
- Product code
- PNF
- Decision code
- APPR
- Decision date
- Jul 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Aortic stent.
- Applicant
- NuMED, Inc.
- Product code
- PNF
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P150028/S007 received
Application receipt date recorded by FDA.
P150028/S007 · FDA decision
Normal 180 Day Track
Timeline entries are records held by MedtechLedger for P150028. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
Other records with product code PNF
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Minima Stent System; Minima Pro Stent SystemP240003/S008 | Renata Medical, Inc. | PMA supplement | Aug 27, 2026 | FDA |
Minima Pro Stent SystemP240003/S006 | Renata Medical, Inc. | PMA supplement | Jul 9, 2026 | FDA |
Minima Stent SystemP240003/S007 | Renata Medical, Inc. | PMA supplement | Feb 11, 2026 | FDA |
Minima Stent SystemP240003/S005 | Renata Medical, Inc. | PMA supplement | Dec 18, 2025 | FDA |
Minima Stent SystemP240003/S004 | Renata Medical, Inc. | PMA supplement | Sep 11, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
NuMED, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 2880 Main St., Hopkinton, NY, 12965
Sources and methodology
- Original FDA record: P150028/S007
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



